The emerging role of glucagon-like peptide 1 in binge eating
Open accessThe DOI matches its Crossref record; 138 of the 141 references it cites were found in a registry or an index; none of the 97 sources its claims cite is checked for support yet.
Abstract
Binge eating is a central component of two clinical eating disorders: binge eating disorder and bulimia nervosa. However, the large treatment gap highlights the need to identify other strategies to decrease binge eating. Novel pharmacotherapies may be one such approach. Glucagon-like peptide-1 (GLP-1) is an intestinal and brain-derived neuroendocrine signal with a critical role in promoting glycemic control through its incretin effect. Additionally, the energy balance effects of GLP-1 are well-established; activation of the GLP-1 receptor (GLP-1R) reduces food intake and body weight. Aligned with these beneficial metabolic effects, there are GLP-1R agonists that are currently used for the treatment of diabetes and obesity. A growing body of literature suggests that GLP-1 may also play an important role in binge eating. Dysregulation of the endogenous GLP-1 system is associated with binge eating in non-human animal models, and GLP-1R agonists may be a promising approach to suppress the overconsumption that occurs during binge eating. Here, we briefly discuss the role of GLP-1 in normal energy intake and reward and then review the emerging evidence suggesting that disruptions to GLP-1 signaling are associated with binge eating. We also consider the potential utility of GLP-1-based pharmacotherapies for reducing binge eating behavior.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 81 Not checked · 20 Own results and interpretations
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“suggesting the physiological relevance of mesolimbic GLP-1R for influencing binge feeding.”
§ The emerging role of glucagon-like peptide-1 in binge eating > 3.1.1 Pharmacological GLP-1R activation and binge-like eating-Interest in
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Animal models cannot fully recapitulate the complexity of human eating disorders, particularly psychological aspects of these disorders”
§ The emerging role of glucagon-like peptide-1 in binge eating > 3.1 Binge-like eating and GLP-1: animal studies
What the sources say
- Not checked yetcites Berner et al., 2020
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“one study using a GLP-1/ estrogen conjugate showed increased efficacy of the conjugate in reducing binge-like eating in ovariectomized mice compared to the suppression of this behavior produced by GLP-1 alone”
§ The emerging role of glucagon-like peptide-1 in binge eating > 3.1.1 Pharmacological GLP-1R activation and binge-like eating-Interest in
What the sources say
- Not checked yetcites Cao et al., 2014
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“GLP-1R agonists have been shown to decrease self-administration of and motivation for substances including alcohol”
§ The emerging role of glucagon-like peptide-1 in binge eating > 2. Glucagon-like peptide-1 2.1 What is GLP-1?
What the sources say
- Not checked yetcites Sorensen et al., 2016
- Not checked yetcites Schmidt et al., 2016
- Not checked yetcites Douton et al., 2022b
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“systemic administration of GLP-1 reduced intake of a sucrose solution in mice given intermittent access to this palatable fluid (Yamaguchi et al., 2017).”
§ The emerging role of glucagon-like peptide-1 in binge eating > 3.1.1 Pharmacological GLP-1R activation and binge-like eating-Interest in
What the sources say
- Not checked yetcites Yamaguchi et al., 2017
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
69 more claims
Create a free account to see all 101 claims and to verify the 97 references still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 19
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Many people who reduce their weight on GLP‐1s experience improved mood, including fewer depressive symptoms [130, 132, 133].”
From Nutritional priorities to support GLP ‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society (2025) · cites this paper as [130]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Many people who reduce their weight on GLP-1s experience improved mood [122,124].”
From Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society (2025) · cites this paper as [122]
Experimental — accuracy not yet measuredIn the citing paper
“Many people who reduce their weight on GLP-1s experience improved mood, including fewer depressive symptoms [130,132,133].”
Citations
Cites
International Journal of Molecular Sciences
(2024) · International Journal of Molecular Sciences · doi:10.3390/ijms · Cited by 10,111
The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication
Hudson, J. I., Hiripi, E., Pope, H. G., & Kessler, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.040 · Cited by 4,973
THE AMERICAN JOURNAL OF PSYCHIATRY: 1844-1944
DUNTON, W. R. (1944) · American Journal of Psychiatry · doi:10.1176/ajp.100.6.45 · Cited by 3,784
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Alcoholism: Clinical and Experimental Research
(2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/(issn)1530-0277 · Cited by 1,831
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444
International Journal of Eating Disorders
(2006) · doi:10.1002/(issn)1098-108x · Cited by 1,147
British Journal of Pharmacology
(2010) · British Journal of Pharmacology · doi:10.1111/(issn)1476-5381 · Cited by 920
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Current Protocols in Neuroscience
(2018) · Current Protocols in Neuroscience · doi:10.1002/(issn)1934-8576 · Cited by 767
Wilfley, D. E., Welch, R. R., Stein, R. I., Spurrell, E. B., Cohen, L. R., Saelens, B. E., Dounchis, J. Z., Frank, M. A., Wiseman, C. V., & Matt, G. E. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.8.713 · Cited by 603
Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-1443 · Cited by 515
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Psychological Treatments of Binge Eating Disorder
Wilson, G. T., Wilfley, D. E., Agras, W. S., & Bryson, S. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.170 · Cited by 492
McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Rosenthal, N. R., Karim, M. R., Kamin, M., & Hudson, J. I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.255 · Cited by 484
Journal of Diabetes and Its Complications
Fonseca, V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.002 · Cited by 463
Cognitive Behavioral Therapy for Eating Disorders
Murphy, R., Straebler, S., Cooper, Z., & Fairburn, C. G. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.004 · Cited by 435
Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14280 · Cited by 427
Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., & Skibicka, K. P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6326-11.2012 · Cited by 414
Addressing critical gaps in the treatment of eating disorders
Kazdin, A. E., Fitzsimmons‐Craft, E. E., & Wilfley, D. E. (2017) · International Journal of Eating Disorders · doi:10.1002/eat.22670 · Cited by 389
Targeted estrogen delivery reverses the metabolic syndrome
Finan, B., Yang, B., Ottaway, N., Stemmer, K., Müller, T. D., Yi, C.-X., Habegger, K., Schriever, S. C., García-Cáceres, C., Kabra, D. G., et al. (2012) · Nature Medicine · doi:10.1038/nm.3009 · Cited by 337
Psychiatric Clinics of North America
(2020) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(20)30021-6 · Cited by 336
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2162 · Cited by 322
(2010) · Frontiers in neuroscience · doi:10.1201/crcfroneusci · Cited by 322
AMERICAN JOURNAL OF CLINICAL NUTRITION
(1998) · Journal of Human Nutrition and Dietetics · doi:10.1046/j.1365-277x.1998.00116.x · Cited by 319
Enhanced Striatal Dopamine Release During Food Stimulation in Binge Eating Disorder
Wang, G., Geliebter, A., Volkow, N. D., Telang, F. W., Logan, J., Jayne, M. C., Galanti, K., Selig, P. A., Han, H., Zhu, W., et al. (2011) · Obesity · doi:10.1038/oby.2011.27 · Cited by 313
The Journal of Comparative Neurology
(1895) · Science · doi:10.1126/science.1.24.672 · Cited by 311
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease.
Baggio, L. L., & Drucker, D. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101090 · Cited by 299
Borcherding, B., Rendleman, R. L., & Walkup, J. T. (2017) · Swaiman's Pediatric Neurology · doi:10.1016/b978-0-323-37101-8.00060-6 · Cited by 286
Central and peripheral GLP-1 systems independently suppress eating
Brierley, D. I., Holt, M. K., Singh, A., de Araujo, A., McDougle, M., Vergara, M., Afaghani, M. H., Lee, S. J., Scott, K., Maske, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00344-4 · Cited by 265
Neuroscience and biobehavioral reviews
McFarland, W. L., Jacobs, M. S., & Morgane, P. J. (1979) · Brain Research Bulletin · doi:10.1016/s0361-9230(79)80030-1 · Cited by 264
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake
Dossat, A. M., Lilly, N., Kay, K., & Williams, D. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3262-11.2011 · Cited by 256
The journal of clinical investigation
(1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)92071-5 · Cited by 253
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Wang, J.-Y., Wang, Q.-W., Yang, X.-Y., Yang, W., Li, D.-R., Jin, J.-Y., Zhang, H.-C., & Zhang, X.-F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085799 · Cited by 248
Archives of General Psychiatry
(2011) · Archives of General Psychiatry · doi:10.1001/archpsyc.68.5.440 · Cited by 244
Freeman, H. (1997) · Current Opinion in Psychiatry · doi:10.1097/00001504-199701000-00001 · Cited by 243
Physiology and Behavior: Parents’ Response to the Infant Cry
Donovan, W. L., & Leavitt, L. A. (1985) · Infant Crying · doi:10.1007/978-1-4613-2381-5_11 · Cited by 199
(1920) · Science · doi:10.1126/science.52.1350.459 · Cited by 195
Mietlicki-Baase, E. G., Ortinski, P. I., Rupprecht, L. E., Olivos, D. R., Alhadeff, A. L., Pierce, R. C., & Hayes, M. R. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00413.2013 · Cited by 174
Self-citationDavis, C. (2013) · Current Obesity Reports · doi:10.1007/s13679-013-0049-8 · Cited by 171
Pharmacology biochemistry and behavior
(1979) · Brain Research Bulletin · doi:10.1016/s0361-9230(79)80031-3 · Cited by 159
Semaglutide for type 2 diabetes mellitus: A systematic review and meta‐analysis
Andreadis, P., Karagiannis, T., Malandris, K., Avgerinos, I., Liakos, A., Manolopoulos, A., Bekiari, E., Matthews, D. R., & Tsapas, A. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13361 · Cited by 153
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
Knerr, P. J., Mowery, S. A., Douros, J. D., Premdjee, B., Hjøllund, K. R., He, Y., Kruse Hansen, A. M., Olsen, A. K., Perez-Tilve, D., DiMarchi, R. D., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101533 · Cited by 152
Vallöf, D., Maccioni, P., Colombo, G., Mandrapa, M., Jörnulf, J. W., Egecioglu, E., Engel, J. A., & Jerlhag, E. (2016) · Addiction Biology · doi:10.1111/adb.12295 · Cited by 150
Schmidt, H. D., Mietlicki-Baase, E. G., Ige, K. Y., Maurer, J. J., Reiner, D. J., Zimmer, D. J., Van Nest, D. S., Guercio, L. A., Wimmer, M. E., Olivos, D. R., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.362 · Cited by 148
Self-citationRentzeperi, E., Pegiou, S., Koufakis, T., Grammatiki, M., & Kotsa, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030454 · Cited by 140
Sørensen, G., Reddy, I. A., Weikop, P., Graham, D. L., Stanwood, G. D., Wortwein, G., Galli, A., & Fink-Jensen, A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.013 · Cited by 140
López-Ferreras, L., Richard, J. E., Noble, E. E., Eerola, K., Anderberg, R. H., Olandersson, K., Taing, L., Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.187 · Cited by 135
Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice
Cao, X., Xu, P., Oyola, M. G., Xia, Y., Yan, X., Saito, K., Zou, F., Wang, C., Yang, Y., Hinton, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74726 · Cited by 131
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_641 · Cited by 125
Hernandez, N. S., Ige, K. Y., Mietlicki-Baase, E. G., Molina-Castro, G. C., Turner, C. A., Hayes, M. R., & Schmidt, H. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0010-3 · Cited by 123
Self-citationMietlicki-Baase, E. G., Ortinski, P. I., Reiner, D. J., Sinon, C. G., McCutcheon, J. E., Pierce, R. C., Roitman, M. F., & Hayes, M. R. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0115-14.2014 · Cited by 121
Self-citationRobert, S. A., Ghani, R. A., Shah, S. A., Chinna, K., Mohamud, W. N. W., & Kamaruddin, N. A. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.03.005 · Cited by 115
Corwin, R. L. (2003) · Appetite · doi:10.1016/j.appet.2003.08.010 · Cited by 115
GLP-1 analog attenuates cocaine reward
Graham, D. L., Erreger, K., Galli, A., & Stanwood, G. D. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.141 · Cited by 114
Effects of limited access to a fat option on food intake and body composition in female rats
Dimitriou, S. G., Rice, H. B., & Corwin, R. L. (2000) · International Journal of Eating Disorders · doi:10.1002/1098-108x(200012)28:4<436::aid-eat12>3.0.co;2-p · Cited by 108
Sex and estrogens alter the action of glucagon-like peptide-1 on reward
Richard, J. E., Anderberg, R. H., López-Ferreras, L., Olandersson, K., & Skibicka, K. P. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0059-9 · Cited by 102
Alhadeff, A. L., Mergler, B. D., Zimmer, D. J., Turner, C. A., Reiner, D. J., Schmidt, H. D., Grill, H. J., & Hayes, M. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.246 · Cited by 102
Meal-Anticipatory Glucagon-Like Peptide-1 Secretion in Rats
Vahl, T. P., Drazen, D. L., Seeley, R. J., D'Alessio, D. A., & Woods, S. C. (2010) · Endocrinology · doi:10.1210/en.2009-1002 · Cited by 101
A Role for GLP-1 in Treating Hyperphagia and Obesity
Grill, H. J. (2020) · Endocrinology · doi:10.1210/endocr/bqaa093 · Cited by 101
Anatomy of a binge: Food environment and characteristics of nonpurge binge episodes
Allison, S., & Timmerman, G. M. (2005) · Eating Behaviors · doi:10.1016/j.eatbeh.2005.01.004 · Cited by 100
Richards, J., Bang, N., Ratliff, E. L., Paszkowiak, M. A., Khorgami, Z., Khalsa, S. S., & Simmons, W. K. (2023) · Obesity Pillars · doi:10.1016/j.obpill.2023.100080 · Cited by 96
Estradiol is a critical regulator of food-reward behavior
Richard, J. E., López‐Ferreras, L., Anderberg, R. H., Olandersson, K., & Skibicka, K. P. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.014 · Cited by 91
Leggio, L., Hendershot, C. S., Farokhnia, M., Fink-Jensen, A., Klausen, M. K., Schacht, J. P., & Simmons, W. K. (2023) · Nature Medicine · doi:10.1038/s41591-023-02634-8 · Cited by 89
Bradshaw, C. M. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199234110.003.025 · Cited by 88
Dietary energy intake across the menstrual cycle: a narrative review
Rogan, M. M., & Black, K. E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac094 · Cited by 88
Valdivia, S., Cornejo, M. P., Reynaldo, M., De Francesco, P. N., & Perello, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.018 · Cited by 86
Vogel, H., Wolf, S., Rabasa, C., Rodriguez-Pacheco, F., Babaei, C. S., Stöber, F., Goldschmidt, J., DiMarchi, R. D., Finan, B., Tschöp, M. H., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.039 · Cited by 86
Food Addiction and Binge Eating: Lessons Learned from Animal Models
Novelle, M., & Diéguez, C. (2018) · Nutrients · doi:10.3390/nu10010071 · Cited by 86
Binge Eating in Rats with Limited Access to Vegetable Shortening
Corwin, R. L., & Wojnicki, F. H. E. (2006) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0923bs36 · Cited by 85
Chao, A. M., Wadden, T. A., Walsh, O. A., Gruber, K. A., Alamuddin, N., Berkowitz, R. I., & Tronieri, J. S. (2019) · Obesity · doi:10.1002/oby.22653 · Cited by 84
Use of glucagon‐like peptide‐1 receptor agonists in eating disorder populations
Bartel, S., McElroy, S. L., Levangie, D., & Keshen, A. (2024) · International Journal of Eating Disorders · doi:10.1002/eat.24109 · Cited by 81
Da Porto, A., Casarsa, V., Colussi, G., Catena, C., Cavarape, A., & Sechi, L. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.009 · Cited by 80
Hernandez, N. S., O'Donovan, B., Ortinski, P. I., & Schmidt, H. D. (2019) · Addiction Biology · doi:10.1111/adb.12583 · Cited by 79
Oral semaglutide in type 2 diabetes
Anderson, S. L., Beutel, T. R., & Trujillo, J. M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107520 · Cited by 79
Geliebter, A., Hashim, S. A., & Gluck, M. E. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.04.013 · Cited by 78
Journal of Personalized Medicine
(2013) · Journal of Personalized Medicine · doi:10.3390/jpm · Cited by 78
European Journal of Investigation in Health, Psychology and Education
(2019) · European Journal of Investigation in Health Psychology and Education · doi:10.30552/ejihpe · Cited by 77
A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder
Allison, K. C., Chao, A. M., Bruzas, M. B., McCuen‐Wurst, C., Jones, E., McAllister, C., Gruber, K., Berkowitz, R. I., Wadden, T. A., & Tronieri, J. S. (2023) · Obesity Science & Practice · doi:10.1002/osp4.619 · Cited by 75
17-β Estradiol regulates proglucagon-derived peptide secretion in mouse and human α- and L cells
Handgraaf, S., Dusaulcy, R., Visentin, F., Philippe, J., & Gosmain, Y. (2018) · JCI Insight · doi:10.1172/jci.insight.98569 · Cited by 73
Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder
Bello, N. T., & Yeomans, B. L. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1395854 · Cited by 70
Effects of the GLP‐1 Agonist Exendin‐4 on Intravenous Ethanol Self‐Administration in Mice
Sørensen, G., Caine, S. B., & Thomsen, M. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13199 · Cited by 69
Wong, K. J., Wojnicki, F. H. W., & Corwin, R. L. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.02.002 · Cited by 68
Liquid sucrose bingeing in rats depends on the access schedule, concentration and delivery system
Wojnicki, F. H. E., Stine, J. G., & Corwin, R. L. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.002 · Cited by 64
Campeau, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.03152-7 · Cited by 63
Vallöf, D., Vestlund, J., & Jerlhag, E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.020 · Cited by 61
Colvin, K. J., Killen, H. S., Kanter, M. J., Halperin, M. C., Engel, L., & Currie, P. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249710 · Cited by 61
Cabanac, M. (2007) · Humana Press eBooks · doi:10.1385/1-59259-925-7:095 · Cited by 59
Dossat, A. M., Bodell, L. P., Williams, D. L., Eckel, L. A., & Keel, P. K. (2014) · International Journal of Eating Disorders · doi:10.1002/eat.22264 · Cited by 57
Asarian, L., Abegg, K., Geary, N., Schiesser, M., Lutz, T. A., & Bueter, M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.008 · Cited by 57
Neuroscience of Compulsive Eating Behavior
Moore, C. F., Sabino, V., Koob, G. F., & Cottone, P. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00469 · Cited by 56
López-Ferreras, L., Eerola, K., Mishra, D., Shevchouk, O. T., Richard, J. E., Nilsson, F. H., Hayes, M. R., & Skibicka, K. P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.11.005 · Cited by 56
Resting State Hypoconnectivity of Reward Networks in Binge Eating Disorder
Haynos, A. F., Camchong, J., Pearson, C. M., Lavender, J. M., Mueller, B. A., Peterson, C. B., Specker, S. M., Raymond, N. C., & Lim, K. O. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhaa369 · Cited by 56
Naessén, S., Carlström, K., Holst, J. J., Hellström, P. M., & Hirschberg, A. L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.014837 · Cited by 54
Douton, J. E., Horvath, N., Mills‐Huffnagle, S., Nyland, J. E., Hajnal, A., & Grigson, P. S. (2022) · Addiction Biology · doi:10.1111/adb.13117 · Cited by 54
Tiano, J. P., Tate, C. R., Yang, B. S., DiMarchi, R., & Mauvais-Jarvis, F. (2015) · Scientific Reports · doi:10.1038/srep10211 · Cited by 48
McElroy, S. L., Mori, N. N., Guerdjikova, A. I., & Keck, P. E. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2017.12.029 · Cited by 47
Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?
Daniels, D., & Mietlicki-Baase, E. G. (2019) · Diabetes · doi:10.2337/dbi18-0045 · Cited by 46
Self-citationNociceptin receptor antagonist SB 612111 decreases high fat diet binge eating
Hardaway, J. A., Jensen, J., Kim, M., Mazzone, C. M., Sugam, J. A., DiBerto, J. F., Lowery‐Gionta, E. G., Hwa, L. S., Pleil, K. E., Bulik, C. M., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.03.046 · Cited by 43
Spierling, S. R., de Guglielmo, G., Kirson, D., Kreisler, A. D., Roberto, M., George, O., & Zorrilla, E. P. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0538-x · Cited by 43
Waltmann, M., Herzog, N., Horstmann, A., & Deserno, L. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.016 · Cited by 42
Corwin, R. L. (2011) · Current Drug Abuse Reviews · doi:10.2174/1874473711104030174 · Cited by 41
Corwin, R. L., Wojnicki, F. H. E., Zimmer, D. J., Babbs, R. K., McGrath, L. E., Olivos, D. R., Mietlicki‐Baase, E. G., & Hayes, M. R. (2016) · Obesity · doi:10.1002/oby.21626 · Cited by 41
Self-citationHernandez, D. B., Mehta, N., & Geliebter, A. (2019) · Obesity · doi:10.1002/oby.22431 · Cited by 41
Douton, J. E., Acharya, N. K., Stoltzfus, B., Sun, D., Grigson, P. S., & Nyland, J. E. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000685 · Cited by 36
Estradiol modulates the anorexic response to central glucagon-like peptide 1
Maske, C. B., Jackson, C. M., Terrill, S. J., Eckel, L. A., & Williams, D. L. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.05.012 · Cited by 35
An Integrated Approach to Addictive Behaviors: A Study on Vulnerability and Maintenance Factors
Gori, A., Topino, E., Cacioppo, M., Craparo, G., Schimmenti, A., & Caretti, V. (2023) · European Journal of Investigation in Health Psychology and Education · doi:10.3390/ejihpe13030039 · Cited by 34
(2013) · Current Obesity Reports · doi:10.1007/13679.2162-4968 · Cited by 32
Converging vulnerability factors for compulsive food and drug use
Serafine, K. M., O’Dell, L. E., & Zorrilla, E. P. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108556 · Cited by 30
Caldas, N. D. R., Bráulio, V. B., Brasil, M. A. A., Botelho, V. C. S. F., de Carvalho, D. P., Cotrik, E. M., Dantas, J. R., & Zajdenverg, L. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000489 · Cited by 29
Effects of glucagon‐like peptide‐1 and sympathetic stimulation on gastric accommodation in humans1
Andrews, C. N., Bharucha, A. E., Camilleri, M., Low, P. A., Seide, B. M., Burton, D. D., Nickander, K. K., Baxter, K. L., & Zinsmeister, A. R. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00923.x · Cited by 26
Opioidergic consequences of dietary-induced binge eating
Bello, N. T., Patinkin, Z. W., & Moran, T. H. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.032 · Cited by 25
Estrogen and gut satiety hormones in vagus-hindbrain axis
Huang, K.-P., & Raybould, H. E. (2020) · Peptides · doi:10.1016/j.peptides.2020.170389 · Cited by 24
de Moraes, C. E. F., Hay, P., Sichieri, R., Fazzino, T. L., Mourilhe, C., & Appolinário, J. C. (2023) · Behavioral Sciences · doi:10.3390/bs13020149 · Cited by 24
SZMUKLER, G. I. (1983) · Behaviour Research and Therapy · doi:10.1016/0005-7967(83)90100-6 · Cited by 23
Pierce-Messick, Z. J., & Pratt, W. E. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001545 · Cited by 23
Westerberg, D. P., & Waitz, M. L. (2013) · Osteopathic Family Physician · doi:10.1016/j.osfp.2013.06.003 · Cited by 21
Berner, L. A., Sysko, R., Rebello, T. J., Roberto, C. A., & Pike, K. M. (2020) · Journal of Eating Disorders · doi:10.1186/s40337-020-00342-z · Cited by 20
Neuronal activity and reward processing in relation to binge eating
Vrieze, E., & Leenaerts, N. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000895 · Cited by 20
(2019) · Current Drug Abuse Reviews · doi:10.2174/cdar-18744737-671 · Cited by 18
Hynie, S. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90154-0 · Cited by 17
Erina, Y., Yasoshima, Y., & Shimura, T. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.12.034 · Cited by 15
Binge-like palatable food intake in rats reduces preproglucagon in the nucleus tractus solitarius
Mukherjee, A., Hum, A., Gustafson, T. J., & Mietlicki‐Baase, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112830 · Cited by 11
Self-citationStone, J. (2022) · Routledge eBooks · doi:10.4324/9781003171799-4 · Cited by 11
Wojnicki, F. H. E., Babbs, R. K., & Corwin, R. L. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.03.015 · Cited by 10
Diabetes, Obesity and Metabolism
(2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13433 · Cited by 10
An empirical examination of appetite hormones and cognitive and behavioral bulimic symptomatology
Presseller, E. K., Clark, K. E., Fojtu, C., & Juarascio, A. S. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-01009-z · Cited by 9
Mukherjee, A., DiBrog, A. M., & Mietlicki‐Baase, E. G. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113869 · Cited by 8
Self-citation(2019) · Osteopathic Family Physician · doi:10.33181/ofp · Cited by 8
Diabetes, Obesity and Metabolism
(2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13775 · Cited by 7
Diabetes and Metabolic Syndrome
Wilbanks, S. (2012) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2012.09.013 · Cited by 6
Sun, R., Tsunekawa, T., Hirose, T., Yaginuma, H., Taki, K., Mizoguchi, A., Miyata, T., Kobayashi, T., Sugiyama, M., Onoue, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98590-9 · Cited by 6
Corticostriatal dynamics underlying components of binge-like consumption of palatable food in mice
Hildebrandt, B. A., Fisher, H., LaPalombara, Z., Young, M. E., & Ahmari, S. E. (2021) · Appetite · doi:10.1016/j.appet.2023.106462 · Cited by 6
Hildebrandt, B. A., Fisher, H., & Ahmari, S. E. (2023) · Behavioral Neuroscience · doi:10.1037/bne0000550 · Cited by 5
New frontiers in the hunger management involving GLP‐1, taste and oestrogen
Baretić, M. (2022) · Diabetic Medicine · doi:10.1111/dme.14846 · Cited by 2
Merchenthaler (1999) · doi:10.1002/(sici)1096-9861(19990111)403:2<261::aid-cne8>3.0.co;2-5
Research works printed but not linked: 2
- AMERICAN PSYCHIATRIC ASSOCIATION. 2013. Diagnostic and statistical manual of mental disorders (5th ed.)
- Do Rosário Caldas NBraulio VBBrasil MAAFurtado VCSDe Carvalho DPCotrik EMDantas JR & Zajdenverg L2022Binge eating disorder, frequency of depression, and systemic inflammatory state in individuals with obesity–a cross sectional study. Archives of Endocrinology and Metabolism66489–497. (https://doi.org/10.20945/2359-3997000000489) · DOI
Cited by
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.04.023 · Cited by 154
“Many people who reduce their weight on GLP-1s experience improved mood [122,124].”
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · Obesity · doi:10.1002/oby.24336 · Cited by 143
“Many people who reduce their weight on GLP-1s experience improved mood, including fewer depressive symptoms [130, 132, 133].”
GLP-1 and Its Analogs: Does Sex Matter?
Börchers, S., & Skibicka, K. P. (2025) · Endocrinology · doi:10.1210/endocr/bqae165 · Cited by 77
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
He, L., Li, Q., Yang, Y., Li, J., Luo, W., Huang, Y., & Zhong, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1416985 · Cited by 40
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J. P., Butsch, W. S., Christensen, S. M., Gianos, E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2026.100269 · Cited by 41
Metadata
- Authors
- Balantekin, K. N., Kretz, M. J., & Mietlicki-Baase, E. G.
- Affiliations
- University at Buffalo, State University of New York (US)
- Department of Exercise and Nutrition Sciences, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York, USA
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2024-04-17
- Volume
- 262
- Issue
- 1
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- PMC
- PMC11156433
- OpenAlex
- W4394877548
- Cited by
- 38
- References
- 141
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 4
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK120778, R01DK128030)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- glucagon-like peptide-1, binge eating, binge eating disorder, bulimia nervosa, GLP-1 receptor agonists, GLP-1 signaling, energy balance, food intake regulation, food reward
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Bulimia, Energy Intake, Energy Metabolism, Humans, Glucagon-Like Peptide 1, Binge-Eating Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.